← Open Payments lookup

YINGMEI LEE: Open Payments

NPI 1831973692 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,010 in 70 payments from 16 companies in 2025. Trend: 2023 $116 · 2024 $2,108 · 2025 $2,010

Food & beverage: $2,010
CompanyPaymentsAmount
ABBVIE INC.17$452
Enterra Medical, Inc.2$340
Janssen Biotech, Inc.7$244
Takeda Pharmaceuticals U.S.A., Inc.8$192
PFIZER INC.9$160
Madrigal Pharmaceuticals3$95
GENZYME CORPORATION4$88
Lilly USA, LLC3$83
Celltrion USA Inc.4$82
Gilead Sciences, Inc.3$71

Products named: SKYRIZI, TREMFYA, RINVOQ, ENTYVIO, REZDIFFRA, DUPIXENT, XELJANZ, OMVOH.

Industry payments across NV — which companies pay providers there.